Cargando…
GCP III is not the “off-target” for urea-based PSMA ligands
Autores principales: | Lee, Zhenghong, Heston, Warren D., Wang, Xinning, Basilion, James P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382371/ https://www.ncbi.nlm.nih.gov/pubmed/37191680 http://dx.doi.org/10.1007/s00259-023-06265-6 |
Ejemplares similares
-
Should Low Molecular Weight PSMA Targeted Ligands Get Bigger and Use Albumin Ligands for PSMA Targeting?
por: Huang, Steve S., et al.
Publicado: (2017) -
Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA
por: Wang, Yu, et al.
Publicado: (2021) -
Lys-urea-Aad, Lys-urea-Cmc and Lys-urea-Cms as potential pharmacophores for the design of PSMA-targeted radioligands to reduce off-target uptake in kidneys and salivary glands
por: Kuo, Hsiou-Ting, et al.
Publicado: (2023) -
Intracellular vesicle entrapment of nanobubble ultrasound contrast agents targeted to PSMA promotes prolonged enhancement and stability in vivo and in vitro
por: Perera, Reshani H., et al.
Publicado: (2022) -
A perspective on the EANM procedure guidelines for radionuclide therapy with (177)Lu-labelled PSMA-ligands
por: Gericke, Germo
Publicado: (2021)